Stephens Inc’s Veracyte VCYT Stock Holding History

Stephens Inc’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-37,577	Closed	-$957K	–	1282
2023 Q2	$957K	Buy	37,577 +163	+0.4%	+$3.95K	0.02%	564
2023 Q1	$834K	Sell	37,414 -808	-2%	-$19.5K	0.02%	577
2022 Q4	$907K	Sell	38,222 -34,225	-47%	-$795K	0.02%	527
2022 Q3	$1.2M	Sell	72,447 -1,461	-2%	-$32.9K	0.03%	485
2022 Q2	$1.47M	Buy	73,908 +58,631	+384%	+$1.18M	0.03%	448
2022 Q1	$421K	Buy	+15,277	New	+$437K	0.01%	879
2019 Q3	–	Sell	-18,660	Closed	-$532K	–	1205
2019 Q2	$532K	Buy	+18,660	New	+$466K	0.01%	743

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Stephens Inc's VCYT Position: Q3 2023 in Review

Stephens Inc sold out of Veracyte (VCYT) in Q3 2023, closing a stake of 37,577 shares — an estimated $957K sold.

Stephens Inc first reported a position in VCYT in Q2 2019 and held it in 7 quarters. The position peaked at $1.47M in Q2 2022. 236 funds tracked by Wall St. Rank hold VCYT as of Q3 2023.

Stephens Inc reported no remaining Veracyte position as of Q3 2023 after selling out during the quarter.
Stephens Inc sold 37,577 Veracyte shares in Q3 2023, an estimated $957K.
Stephens Inc first reported a position in Veracyte in Q2 2019 and held it in 7 quarters.
Stephens Inc's Veracyte position peaked at $1.47M in Q2 2022.
236 funds tracked by Wall St. Rank held Veracyte as of Q3 2023.

Based on Stephens Inc's 13F filing for Q3 2023, filed 14 Nov 2023.